Anna Hung

Conference Journal of Clinical Oncology · February 20, 2022 47 Background: Practice guidelines have been modified to recommend hereditary and tumor gene mutation testing in patients with metastatic castration-resistant prostate cancer (mCRPC) to identify patients for molecularly targeted ... Full text Cite

Financial interventions to improve medication adherence: a narrative review

Conference INTERNATIONAL JOURNAL OF CLINICAL PHARMACY · February 2022 Link to item Cite

Site investigator perspectives on exclusionary determinations of SWEDDs (Scans Without Evidence of Dopaminergic Deficit) during screening in the SURE-PD3 study

Conference MOVEMENT DISORDERS · September 2020 Link to item Cite

PMU113 NOVEL PEANUT-ALLERGY DESENSITIZATION TREATMENTS: WHO IS LIKELY TO CHOOSE TREATMENT AND WHY

Conference Value in Health · May 2020 Full text Cite

An NLP tool to identify molecular diagnostic testing in veterans with stage IV NSCLC.

Conference Journal of Clinical Oncology · September 20, 2019 318 Background: ASCO Quality Oncology Practice Initiative (QOPI) encourages hospitals to determine if patients (pts) with stage IV NSCLC adenocarcinoma have activating EGFR mutations. Guidelines recommend tumor testing to identif ... Full text Cite

PMS17 ONE-YEAR HEALTHCARE UTILIZATION AND COSTS AFTER KNEE ARTHROPLASTY

Conference Value in Health · May 2019 Full text Cite

TELEPSYCHOLOGY GROUP FOR ADOLESCENTS WITH CF

Conference PEDIATRIC PULMONOLOGY · September 2017 Link to item Cite

EVALUATION OF OPIOID USAGE AND IDENTIFICATION OF RISK FACTORS IN A HIGH RISK URBAN POPULATION

Conference RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY · 2017 Link to item Cite

Real-world Treatment Patterns and the Uptake of Biologics in Elderly Medicare Patients with Metastatic Colon Cancer

Conference ANNALS OF SURGICAL ONCOLOGY · February 2015 Link to item Cite

Real-world treatment patterns and the uptake of biologics in elderly medicare patients with metastatic colon cancer.

Conference Journal of Clinical Oncology · January 20, 2015 540 Background: Metastatic colon cancer (mCC) patients may receive multiple lines of treatment (Tx1, Tx2, etc.) consisting of one or more cytotoxic (CYT: 5FU/LV, oxaliplatin [OX], irinotecan [IRI]) and biologic (BIO: bevacizumab ... Full text Cite

Treatment-related microangiopathic glomerulopathy and severe chronic kidney disease (CKD) in recurrent epithelial ovarian cancer (rEOC): A possible relationship with pegylated liposomal doxorubicin (PLD).

Conference Journal of Clinical Oncology · May 20, 2011 Full text Cite

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluation of preoperative therapy for extremity soft tissue sarcomas (STS).

Conference Journal of Clinical Oncology · May 20, 2011 Full text Cite

Phase I/II study of neoadjuvant docetaxel plus intensity-modulated radiotherapy (IMRT) prior to surgery for high-risk prostate cancer.

Conference Journal of Clinical Oncology · May 20, 2011 Full text Cite

Sorafenib (S) with preoperative chemoradiotherapy for extremity soft tissue sarcomas (STS) and evaluation by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).

Conference Journal of Clinical Oncology · May 20, 2010 Full text Cite

Phase I/II study of preoperative intensity-modulated radiation therapy (IMRT) and docetaxel for high-risk prostate cancer: A platform for radiosensitizer development.

Conference Journal of Clinical Oncology · May 20, 2010 Full text Cite